Targeting CD48 Ameliorates ILC2-mediated Airway Hyperreactivity by Disrupting the PKCbeta Pathway. Sakano K, Sakano Y, Hurrell BP, Kazemi MH, et al. Am J Respir Cell Mol Biol 2026;74:65-79.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sakano K, Sakano Y, Hurrell BP, Kazemi MH, et al. Targeting CD48 Ameliorates ILC2-mediated Airway Hyperreactivity by Disrupting the PKCbeta Pathway. Am J Respir Cell Mol Biol 2026;74:65-79.
PMID: 40720762